BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3243575)

  • 1. [Double-blind evaluation of the effectiveness and tolerance of tipredane cream and betamethasone valerate cream in patients with psoriasis].
    Damasio M; Tacchini GA
    G Ital Dermatol Venereol; 1988 Sep; 123(9):IL-LI. PubMed ID: 3243575
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis.
    Callen J
    Cutis; 1996 Feb; 57(2 Suppl):45-50. PubMed ID: 8646870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 5. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of exzema with flupamesone (Flutenal);a double-blind comparison with bethamethasone-17-valerate. (method of simultaneous symmetrical paired comparisons).
    Moreno TR; Canas TR; Mestre JM
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):183-6. PubMed ID: 403053
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical investigation of halopredone acetate, a new topical steroid, in dermatology. Controlled study.
    Palmerio B; Magnani P
    Arzneimittelforschung; 1977; 27(12):2404-6. PubMed ID: 341905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hydrocortisone butyrate (Locoid) compared with betamethasone valerate. A controlled clinical trail].
    Thormann J
    Ugeskr Laeger; 1976 Jan; 138(4):214-6. PubMed ID: 766347
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical corticosteroids in seborrhoeic dermatitis. A report from The General Practitioner Research Group.
    Practitioner; 1982 Jun; 226(1368):1178-9. PubMed ID: 6213951
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P; Harncharoen K
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between 2 steroid dosage forms in psoriasis and eczema].
    Björnberg A; Hellgren L
    Z Hautkr; 1975; Suppl 2():13-5. PubMed ID: 779298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: treatment with a new topical corticosteroid.
    Kanof NB; Blau S
    Cutis; 1976 Apr; 17(4):796-8. PubMed ID: 797543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences with a new topical steroid].
    Meyer-Rohn J
    Z Hautkr; 1975; Suppl 2():3-6. PubMed ID: 1229217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A test of the half-side comparative design in the clinical evaluation of topical steroids, using diflucortolone and betamethasone creams.
    August PJ; Platt NE; Wiseman RA
    Br J Clin Pract; 1985 Oct; 39(10):383-7. PubMed ID: 3907679
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
    Woodford R
    Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.